Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

- Parkinson's Disease
- Completed

Study Title: Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

Teva Identifier: TVP-1012/PM103

ClinicalTrials.gov Identifier: NCT01049984

Study Status: Completed

Trial Condition(s): Parkinson's Disease

Interventions: Drug: Rasagiline | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 30 Years and older

Trial Duration: 12/01/2009 - 10/01/2012

Phase: Phase 4

Study Type

Interventional